ML18025B269: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 17: | Line 17: | ||
=Text= | =Text= | ||
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 22, 2018 MEMORANDUM TO: | {{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 22, 2018 MEMORANDUM TO: Brian E. Thomas, Director Division of Engineering Office of Nuclear Regulatory Research FROM: Thomas H. Boyce, Chief /RA/ | ||
Regulatory Guidance and Generic Issues Branch Division of Engineering Office of Nuclear Regulatory Research | |||
FROM: | |||
RA/ Regulatory Guidance and Generic Issues Branch | |||
==SUBJECT:== | ==SUBJECT:== | ||
RESULTS OF PERIODIC REVIEW OF REGULATORY GUIDE 8.26 | RESULTS OF PERIODIC REVIEW OF REGULATORY GUIDE 8.26 This memorandum documents the U.S. Nuclear Regulatory Commission (NRC) periodic reviews of Regulatory Guide (RG) 8.26, Revision 0, Applications of Bioassay for Fission and Activation Products. As discussed in Management Directive 6.6, Regulatory Guides, the NRC staff reviews RGs periodically to ensure that the RGs continue to provide useful guidance. | ||
This memorandum documents the U.S. Nuclear Regulatory Commission (NRC) periodic reviews of Regulatory Guide (RG) 8.26, Revision 0, | |||
Documentation of the NRC staff reviews is enclosed with a brief description listed below: | Documentation of the NRC staff reviews is enclosed with a brief description listed below: | ||
* RG 8.26 has been reviewed with issues identified for future consideration. The staff will consider revising Revision 0 to RG 8.26 if more substantive changes to applicable standards are published, or if the staff finds that further guidance is needed in the implementation of bioassay for fission and activation products. | * RG 8.26 has been reviewed with issues identified for future consideration. The staff will consider revising Revision 0 to RG 8.26 if more substantive changes to applicable standards are published, or if the staff finds that further guidance is needed in the implementation of bioassay for fission and activation products. | ||
==Enclosures:== | ==Enclosures:== | ||
Regulatory Guide Periodic Reviews CONTACTS: Casper Sun, RES/DSA/RPB 301-415-1646 Steve Garry, NRR/DRA/ARCB 301-415-2766 | Regulatory Guide Periodic Reviews CONTACTS: Casper Sun, RES/DSA/RPB 301-415-1646 Steve Garry, NRR/DRA/ARCB 301-415-2766 | ||
ML18024B347 OFFICE RES/DE/RGGIB RES/RSA/ | ML18024B347 OFFICE RES/DE/RGGIB RES/RSA/RPB NRR/DRA/ARCB NAME J. Parks R. Tadesse S. Garry DATE 12/ 18 /17 12/ 18 /17 12/ 17 /17 OFFICE NRR/DRA/ARCB RES/DE/RGGI SUNSI Review RES/DE/RGGIB B | ||
NAME K. Hsueh H. Karagiannis H. Karagiannis T. Boyce DATE 1/ 19 /18 1/ 19 /187 1/ 19 /18 1/ 22 /18}} | |||
Latest revision as of 01:29, 22 October 2019
| ML18025B269 | |
| Person / Time | |
|---|---|
| Issue date: | 01/22/2018 |
| From: | Boyce T NRC/RES/DE/RGDB |
| To: | Bernard Thomas NRC/RES/DE |
| Karagiannis H | |
| Shared Package | |
| ML18024B347 | List: |
| References | |
| RG-8.026 | |
| Download: ML18025B269 (2) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 22, 2018 MEMORANDUM TO: Brian E. Thomas, Director Division of Engineering Office of Nuclear Regulatory Research FROM: Thomas H. Boyce, Chief /RA/
Regulatory Guidance and Generic Issues Branch Division of Engineering Office of Nuclear Regulatory Research
SUBJECT:
RESULTS OF PERIODIC REVIEW OF REGULATORY GUIDE 8.26 This memorandum documents the U.S. Nuclear Regulatory Commission (NRC) periodic reviews of Regulatory Guide (RG) 8.26, Revision 0, Applications of Bioassay for Fission and Activation Products. As discussed in Management Directive 6.6, Regulatory Guides, the NRC staff reviews RGs periodically to ensure that the RGs continue to provide useful guidance.
Documentation of the NRC staff reviews is enclosed with a brief description listed below:
- RG 8.26 has been reviewed with issues identified for future consideration. The staff will consider revising Revision 0 to RG 8.26 if more substantive changes to applicable standards are published, or if the staff finds that further guidance is needed in the implementation of bioassay for fission and activation products.
Enclosures:
Regulatory Guide Periodic Reviews CONTACTS: Casper Sun, RES/DSA/RPB 301-415-1646 Steve Garry, NRR/DRA/ARCB 301-415-2766
ML18024B347 OFFICE RES/DE/RGGIB RES/RSA/RPB NRR/DRA/ARCB NAME J. Parks R. Tadesse S. Garry DATE 12/ 18 /17 12/ 18 /17 12/ 17 /17 OFFICE NRR/DRA/ARCB RES/DE/RGGI SUNSI Review RES/DE/RGGIB B
NAME K. Hsueh H. Karagiannis H. Karagiannis T. Boyce DATE 1/ 19 /18 1/ 19 /187 1/ 19 /18 1/ 22 /18